|
Ross A. Longhini was named Chief Executive Officer (interim) in January 2008. Prior to his appointment Mr. Longhini served as Executive Vice-President and Chief Operating Officer (August 2006 - January 2008) and as Chief Technology Officer at AMS. Mr. Longhini has more than 20 years of experience in the field of medical device product development. From 1998 to 2002 he served in various management positions in Sulzer Spine-Tech of Minnesota including Vice President Research and Development Clinical & Regulatory. From 1991 to 1998 he was with I.V. Infusion Therapy of 3M which was sold to Gaseby in 1996 then purchased by Smiths Medical Systems in 1997. From 1983 to 1991 he was with 3M Dental Products. | 